E. Gaillard (Leicester (Leicestershire), United Kingdom), K. Kainz (Wien, Austria)
This session is built from abstracts published on the ERS Congress platform from 23 August, in an e-poster pdf format with a 3-minute audio narration. Participants and chairs of the session are invited to access all e-posters from 23 August to 4 September prior to the 1-hour live, online discussion scheduled from September 5-7. Please note that during live discussion there will be NO e-poster/abstract presentations, only discussion.
Stop omalizumab: a multicenter follow up study after discontinuation in pediatric patients with severe asthma
V. Ferraro (Padova, Italy), A. Licari (Pavia, Italy), A. Volpini (Ancona, Italy), G. Fenu (Florence, Italy), M. Seminara (Bergamo, Italy), F. Rusconi (Florence, Italy)
|   |
Characterisation of a paediatric population referred for a dysfunctional breathing assessment
L. Blazey (Edinburgh, United Kingdom), P. Seta (Edinburgh, United Kingdom), K. Macleod (Edinburgh, United Kingdom), K. Unger (Edinburgh, United Kingdom)
| |
Use of Omalizumab in children in real clinical practice.
S. Zaytseva (Moscow, Russian Federation), O. Zaytseva (Moscow, Russian Federation), E. Lokshina (Moscow, Russian Federation), A. Tomilova (Moscow, Russian Federation), O. Voronina (Moscow, Russian Federation), O. Murtazaeva (Moscow, Russian Federation), . Mukhortykh (Moscow, Russian Federation), I. Tsymbal (Moscow, Russian Federation)
| |
Adverse drug reactions of leukotriene receptor antagonists in children with asthma: a systematic review
E. Dixon (Liverpool, United Kingdom), C. Rugg-Gunn (Liverpool, United Kingdom), I. Sinha (Liverpool, United Kingdom), D. Hawcutt (Liverpool, United Kingdom)
| |
Dupilumab improves asthma control and quality of life in children with uncontrolled persistent asthma
A. Fiocchi (Rome, Italy), W. Phipatanakul (Boston, United States of America), S. Durrani (Cincinnati, United States of America), J. Cole (Edmund, United States of America), X. Mao (Bridgewater, United States of America), J. Msihid (Chilly-Mazarin, France), D. Lederer (Tarrytown, United States of America), M. Hardin (Cambridge, United States of America), Y. Zhang (Tarrytown, United States of America), A. Khan (Chilly-Mazarin, France)
| |
A systematic review of the proportion of adolescents recruited to RCTs of asthma treatments for adults and adolescents.
A. Nuttall (Liverpool, United Kingdom), E. Wilkinson (Liverpool, United Kingdom), W. Bedson (Liverpool, United Kingdom), I. Sinha (Liverpool, United Kingdom), P. Mcnamara (Liverpool, United Kingdom)
| |
Clinical utility of impulse oscillometry (IOS) versus multiple breath washout (MBW) in school-age asthma
S. Kjellberg (Gothenburg, Sweden), A. Olin (Gothenburg, Sweden), P. Robinson (Sydney, Australia)
| |
Mould in the homes of asthmatic children is associated with socioeconomic deprivation, reduced lung function and unscheduled healthcare visits
K. Holden (Leicester (Leicestershire), United Kingdom), K. Welsh (Leicester (Leicestershire), United Kingdom), A. Wardlaw (Leicester (Leicestershire), United Kingdom), J. Satchwell (Leicester (Leicestershire), United Kingdom), W. Monteiro (Leicester (Leicestershire), United Kingdom), C. Pashley (Leicester (Leicestershire), United Kingdom), E. Gaillard (Leicester (Leicestershire), United Kingdom)
| |
Asthma control, exacerbations, airway obstruction and reversibility in children before and after SARS-CoV-2 pandemic onset
N. Beydon (Paris, France), F. Coquelin (Paris, France)
| |
The various questions asked by parents about their children's asthma
Z. israa (rabat, Morocco), J. Ghizlane (rabat, Morocco), B. Soukaina (rabat, Morocco), B. Fadwa (rabat, Morocco), E. Naïma (rabat, Morocco), B. Soumia (rabat, Morocco), M. Chafiq (rabat, Morocco)
| |
The value of magnesium sulfate nebulization in moderate to severe asthma exacerbations in childrenDepartment of pneumo-allergology and pediatric infectious disease Children's hospital CHU Ibn Sina Rabat morocco
f. yatribi (RABAT, Morocco), S. Batali (RABAT, Morocco), S. Benchekroun (RABAT, Morocco), N. Hafidi (RABAT, Morocco), C. Mahraoui (RABAT, Morocco)
| |
Long-term effects of multidisciplinary inpatient asthma treatment
Y. Van Dijk (Amsterdam, Netherlands), M. Trijbels (Hilversum, Netherlands), B. Van Ewijk (Amsterdam, Netherlands)
| |
Deprescribing montelukast in children with asthma: a systematic review
E. Dixon (Liverpool, United Kingdom), C. King (Liverpool, United Kingdom), D. Hawcutt (Liverpool, United Kingdom), I. Sinha (Liverpool, United Kingdom)
| |
Evaluation of the teach-to-goal method in improving inhaler technique in paediatric asthma patients
O. Mallon (Belfast, United Kingdom), M. Shields (Belfast, United Kingdom), D. O'Donoghue (Belfast, United Kingdom), P. Mc Crossan (Belfast, United Kingdom)
| |
Assessment of current practice of paediatric respiratory and allergy teams in Cambridge University Hospital during the COVID-19 pandemic era and optimisation of the service
E. Powell (Cambridge, United Kingdom), S. Nethercott (Cambridge, United Kingdom), A. Ali (Cambridge, United Kingdom), G. Wilson (Cambridge, United Kingdom), Z. Zolkipli (Cambridge, United Kingdom), D. Mcshane (Cambridge, United Kingdom), D. Kotzia (Cambridge, United Kingdom)
| |
Monoclonal antibody treatments for paediatric severe asthma–outcomes, attitudes and adherence
M. Sheppard (Sydney, Australia), A. Kevat (Brisbane , Australia), L. Owens (Sydney, Australia), M. Gray (Sydney, Australia)
| |
Impact of COVID-19 side-effects on pediatric and adult patients with recurrent wheeze and asthma
N. Maison (Munich, Germany), H. Herbrüggen (Großhansdorf, Germany), B. Schaub (Munich, Germany), C. Schauberger (Munich, Germany), S. Foth (Marburg, Germany), R. Grychtol (Hannover, Germany), M. Abdo (Großhansdorf, Germany), H. Watz (Großhansdorf, Germany), W. Nikolaizik (Marburg, Germany), K. Rabe (Großhansdorf, Germany), M. Kopp (Bern, Switzerland), G. Hansen (Hannover, Germany), E. Von Mutius (Munich, Germany), T. Bahmer (Großhansdorf, Germany), J. Omony (Munich, Germany)
| |
Evidence of early abnormal airways’ inflammation in children with type 1 diabetes
M. Saad (Milano, Italy), E. Franceschi (Milano, Italy), S. Pini (Milano, Italy), G. Croce (Milano, Italy), L. Perotto (Milano, Italy), M. Rizzi (Milano, Italy), D. Radovanovic (Milano, Italy), P. Santus (Milano, Italy), D. Radovanovic (Milano (MI), Italy)
| |